Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3549 USD | -4.75% | -13.75% | -38.28% |
05-09 | Transcript : Virios Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Virios Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gregory Duncan
CEO | Chief Executive Officer | 59 | 31/12/17 |
Angela Walsh
DFI | Director of Finance/CFO | 58 | 31/03/20 |
Ralph Grosswald
COO | Chief Operating Officer | 55 | 31/03/20 |
R. Gendreau
CTO | Chief Tech/Sci/R&D Officer | 68 | 27/02/12 |
Richard Burch
BRD | Director/Board Member | 67 | 31/12/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Thomas
BRD | Director/Board Member | 70 | 20/12/20 |
Richard Whitley
BRD | Director/Board Member | 78 | 20/12/20 |
Gregory Duncan
CEO | Chief Executive Officer | 59 | 31/12/17 |
Abel de la Rosa
BRD | Director/Board Member | 61 | 20/12/20 |
William Pridgen
FOU | Founder | 63 | 27/02/12 |
Richard Burch
BRD | Director/Board Member | 67 | 31/12/13 |
David Keefer
BRD | Director/Board Member | 71 | 31/12/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,257,937 | 17,387,608 ( 90.29 %) | 0 | 90.29 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.28% | 6.83M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- VIRI Stock
- Company Virios Therapeutics, Inc.